FI59535C - Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom - Google Patents

Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom Download PDF

Info

Publication number
FI59535C
FI59535C FI781233A FI781233A FI59535C FI 59535 C FI59535 C FI 59535C FI 781233 A FI781233 A FI 781233A FI 781233 A FI781233 A FI 781233A FI 59535 C FI59535 C FI 59535C
Authority
FI
Finland
Prior art keywords
strain
vaccine
newcastle disease
newcastle
lasota
Prior art date
Application number
FI781233A
Other languages
English (en)
Finnish (fi)
Other versions
FI781233A (fi
FI59535B (fi
Inventor
Jacqueline Gits
Nathan Zygraich
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of FI781233A publication Critical patent/FI781233A/fi
Publication of FI59535B publication Critical patent/FI59535B/fi
Application granted granted Critical
Publication of FI59535C publication Critical patent/FI59535C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI781233A 1977-04-25 1978-04-21 Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom FI59535C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE853923 1977-04-25
BE853923 1977-04-25

Publications (3)

Publication Number Publication Date
FI781233A FI781233A (fi) 1978-10-26
FI59535B FI59535B (fi) 1981-05-29
FI59535C true FI59535C (fi) 1981-09-10

Family

ID=3861522

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781233A FI59535C (fi) 1977-04-25 1978-04-21 Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom

Country Status (22)

Country Link
US (1) US4235876A (es)
AR (1) AR218304A1 (es)
AT (1) AT358166B (es)
BE (1) BE853923A (es)
CA (1) CA1113860A (es)
CH (1) CH641047A5 (es)
DE (1) DE2817891A1 (es)
DK (1) DK160878A (es)
FI (1) FI59535C (es)
FR (1) FR2388564A1 (es)
GB (1) GB1593567A (es)
HU (1) HU179290B (es)
IE (1) IE46943B1 (es)
IL (1) IL54390A (es)
IT (1) IT1113070B (es)
LU (1) LU79508A1 (es)
NL (1) NL7804182A (es)
NO (1) NO153010C (es)
PH (1) PH14085A (es)
PT (1) PT67868B (es)
SE (1) SE430752B (es)
ZA (1) ZA781832B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
ES2188593T3 (es) * 1992-03-24 2003-07-01 United Cancer Res Inst Vacuna que contiene un virus vivo.
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
KR101481164B1 (ko) * 2008-01-30 2015-01-09 주식회사 미래셀바이오 체세포 유래 다능성 줄기세포의 제조 방법
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3548054A (en) * 1969-06-06 1970-12-15 Lilly Co Eli Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines

Also Published As

Publication number Publication date
IT7822203A0 (it) 1978-04-11
NO781421L (no) 1978-10-26
PH14085A (en) 1981-02-10
FR2388564A1 (fr) 1978-11-24
CA1113860A (en) 1981-12-08
DK160878A (da) 1978-10-26
IE46943B1 (en) 1983-11-16
FI781233A (fi) 1978-10-26
FR2388564B1 (es) 1980-07-25
IL54390A (en) 1980-11-30
NO153010B (no) 1985-09-23
ZA781832B (en) 1979-03-28
NL7804182A (nl) 1978-10-27
HU179290B (en) 1982-09-28
IL54390A0 (en) 1978-06-15
ATA292278A (de) 1980-01-15
LU79508A1 (fr) 1978-09-29
AR218304A1 (es) 1980-05-30
BE853923A (fr) 1977-10-25
SE430752B (sv) 1983-12-12
SE7804116L (sv) 1978-10-26
PT67868B (en) 1979-10-10
CH641047A5 (en) 1984-02-15
FI59535B (fi) 1981-05-29
GB1593567A (en) 1981-07-22
IT1113070B (it) 1986-01-20
NO153010C (no) 1986-01-02
US4235876A (en) 1980-11-25
DE2817891A1 (de) 1978-11-09
IE780811L (en) 1978-10-25
AT358166B (de) 1980-08-25
PT67868A (en) 1978-05-01

Similar Documents

Publication Publication Date Title
FI59535C (fi) Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom
Miller et al. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge
Choi et al. An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea
Steensels et al. Prime–boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI
US4338296A (en) Influenza virus and process of producing a vaccine therefrom
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
US4053583A (en) Live newcastle disease virus vaccines
HU226256B1 (en) A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
WO2007118284A1 (en) Influenza virus vaccine
AU2008364200B2 (en) Recombinant inactivated viral vector vaccine
Kiyotani et al. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity
CA1152895A (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
WO2021211553A1 (en) Recombinant vaccine against marek's disease and newcastle disease
RU2507256C2 (ru) Штамм вируса гриппа а/17/mallard/нидерланды/00/95(h7n3) для производства живой и производства инактивированной гриппозных вакцин
US3897549A (en) Herpes simplex type 2 virus vaccine and method of production and use
CN102234637B (zh) 重组甲型h1n1流感病毒灭活疫苗株(sc/pr8)的制备及应用
Kydyrbayev et al. Immunogenicity of the inactivated oil emulsion influenza A (H5N1) vaccine in chickens
CN104109655B (zh) H7亚型禽流感疫苗和诊断试剂所需种毒的制备方法
KR810001063B1 (ko) 생 뉴캣슬(Newcastle)병 바이러스 백신의 제법
Omar et al. EVALUATION OF RECOMBINANT AVIAN INFLUENZA COMPARED TO INACTIVATED VACCINES TO INDUCE IMMUNE RESPONSE IN CHICKEN
El-Bagoury et al. Efficacy of Inactivated Avian Influenza H5N1 Vaccine in SPF chicken against Avian Influenza Viruses H5N2 and H5N8 (Egyptian Isolates)
RU2127603C1 (ru) Инактивированная вакцина против инфекционной бурсальной болезни птиц
KR101753978B1 (ko) 고병원성 조류 인플루엔자(h5n1) 및 뉴캣슬병 바이러스 융합 바이러스 유사 입자 백신 및 이를 이용한 백신
KR20220108440A (ko) 조류 인플루엔자 바이러스 유사 입자 및 이를 포함하는 백신 조성물

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SMITH KLINE - RIT